Elastin Biosciences
Platform to Tackle Elastin Loss
About Us
Elastin Bioscience Company
Elastin Biosciences, a spin-out from Longaevus Technologies, is pioneering therapeutics that restore the body’s structural foundation.
By addressing extracellular matrix deterioration — a newly recognized hallmark of aging — we target a shared mechanism underlying cardiovascular, pulmonary, and dermal degeneration.
What Is
_____
Elastin ?
Elastin, is one of the most dominant proteins in the body expressed in the:
Lungs
Skin
Vascular System
The vast majority of elastin is deposited before adolescence, with synthesis essentially halting thereafter.
As We Age
___________
Elastin loss
Elastin degrades over time due to mechanical stress, chronic inflammation, UV damage and a wide variety of diseases.
This not only leads to loss of structural integrity. The by-products of elastin degradation are biochemically active and further drive the aging process.
Our Approach
______________
Elastin Restoration Platform
At Elastin Bioscienes, our team is developing an Elastin Restoration Platform to tackle elastin loss. Our approach develops a continuous pipeline of small molecules using cheminformatics, testing on human cells followed by testing on disease models of Elastin-related diseases.
Pipeline
_______________
Our small molecule assets developed at Elastin Biosciences mark a new era in elastin research. These molecules are designed to not only boost elastin production but also to fortify the structural integrity of crucial tissues, particularly in the cardiovascular system.
In Vivo Success: Our research has yielded promising results beyond theoretical confines, showcasing significant increases in elastin expression and enhanced arterial strength in our in vivo studies.
Contact Us
Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!